{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:50:24Z","timestamp":1777614624676,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Biologica Hungarica"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1556\/abiol.61.2010.3.11","type":"journal-article","created":{"date-parts":[[2010,8,20]],"date-time":"2010-08-20T01:08:26Z","timestamp":1282266506000},"page":"356-365","source":"Crossref","is-referenced-by-count":16,"title":["Antifungal activity of statins and their interaction with amphotericin B against clinically important Zygomycetes"],"prefix":"10.1007","volume":"61","author":[{"given":"L.","family":"Galg\u00f3czy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u00f6ngyi","family":"Luk\u00e1cs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ildik\u00f3","family":"Nyilasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Papp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cs.","family":"V\u00e1gv\u00f6lgyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1128\/AAC.00452-07","article-title":"In vitro susceptibilities of 217 clinical isolates of Zygomycetes to conventional and new antifungal agents","volume":"51","author":"Almyroudis N. G.","year":"2007","journal-title":"Antimicrob. Agents. Ch."},{"key":"2","first-page":"III-50","article-title":"Safety of statins: Focus on clinical pharmacokinetics and drug interactions","volume":"109","author":"Bellosta S.","year":"2004","journal-title":"American Heart Association, Circulation"},{"key":"3","first-page":"7","article-title":"Statins in the prevention of cardiovascular events in patients with renal failure","volume":"7","author":"Buemi M.","year":"2007","journal-title":"Cardiovasc. Haematol. Disord. Drug. Targets"},{"key":"4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/AAC.50.1.96-103.2006","article-title":"Lovastatin has significant activity against Zygomycetes and interacts synergistically with voriconazole","volume":"50","author":"Chamilos G.","year":"2006","journal-title":"Antimicrob. Agents. Ch."},{"key":"5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10096-006-0107-1","article-title":"Zygomycosis: the re-emerging fungal infection","volume":"25","author":"Chayakulkeeree M.","year":"2006","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"6","doi-asserted-by":"crossref","first-page":"34202","DOI":"10.1074\/jbc.M505268200","article-title":"Mechanism of statin-mediated inhibition of small G-protein function","volume":"280","author":"Cordle A.","year":"2005","journal-title":"J. Biol. Chem."},{"key":"7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0163-7258(99)00045-5","article-title":"New insights into the pharmacodynamic and pharmacokinetic properties of statins","volume":"84","author":"Corsini A.","year":"1999","journal-title":"Pharmacolo. Therapeut."},{"key":"8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amjcard.2005.08.007","article-title":"Pharmacokinetic interactions between statins and fibrates","volume":"96","author":"Corsini A.","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"9","volume-title":"Antibiotics in Laboratory Medicine","author":"Eliopoulos G. M.","year":"1996"},{"key":"10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1574-6968.2007.00661.x","article-title":"Interactions between statins and Penicillium chrysogenum antifungal protein (PAF) to inhibit the germination of sporangiospores of different sensitive Zygomycetes","volume":"270","author":"Galg\u00f3czy L.","year":"2007","journal-title":"FEMS Microbiol. Lett."},{"key":"11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1439-0507.2008.01634.x","article-title":"In vitro interaction between suramin and fluvastatin against clinically important Zygomycetes","volume":"52","author":"Galg\u00f3czy L.","year":"2009","journal-title":"Mycoses."},{"key":"12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1517\/14656566.4.2.147","article-title":"Antifungal pharmacotherapy for invasive mould infections","volume":"4","author":"Gallagher C. G.","year":"2003","journal-title":"Expt. Opin. Pharmacother."},{"key":"13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1096\/fj.04-2702fje","article-title":"Simvastatin inhibits T cell activation by selectively impairing the function of Ras superfamily GTPases","volume":"19","author":"Ghittoni R.","year":"2005","journal-title":"The FASEB Journal"},{"key":"14","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1086\/315643","article-title":"Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans","volume":"182","author":"Groll A. H.","year":"2000","journal-title":"J. Infect. Dis."},{"key":"15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1527-3466.2003.tb00116.x","article-title":"Pitavastatin: Efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor","volume":"21","author":"Kajinami K.","year":"2003","journal-title":"Cardiovasc. Drug. Rev."},{"key":"16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jac\/dkh025","article-title":"Study of the toxicity of a new lipid complex formulation of amphotericin B","volume":"53","author":"Larabi M.","year":"2004","journal-title":"J. Antimicrob. Chemoth."},{"key":"17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1172\/JCI0216421","article-title":"Isoprenoids as mediators of the biological effects of statins","volume":"110","author":"Liao J. K.","year":"2002","journal-title":"J. Clin. Invest."},{"key":"18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao J. K.","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"19","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1128\/AAC.34.9.1660","article-title":"Effects of Lovastatin (Mevinolin) on sterol levels and on activity of azoles in Saccharomyces cerevisiae","volume":"34","author":"Lorenz R. T.","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"20","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1128\/JCM.42.11.5400-5402.2004","article-title":"Differentiation of Rhizomucor species on the basis of their different sensitivities to lovastatin","volume":"42","author":"Luk\u00e1cs Gy.","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10482-008-9287-2","article-title":"Cloning of the Rhizomucor miehei 3-hydroxy-3-methylglutaryl-coenzyme A reductase gene and its heterologous expression in Mucor circinelloides","volume":"95","author":"Luk\u00e1cs Gy.","year":"2008","journal-title":"Anton. Leeuw. Int. J. G."},{"key":"22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5551\/jat.11.253","article-title":"Cholesterol-independent effects of statins and new therapeutic strategies: ischemic stroke and dementia","volume":"11","author":"Miida T.","year":"2004","journal-title":"J. Atheroscler. Thromb."},{"key":"23","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1469-0691.2003.00755.x","article-title":"In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates","volume":"9","author":"Minassian B.","year":"2003","journal-title":"Clin. Microbiol. Infect."},{"key":"24","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1094\/PHYTO.2003.93.11.1344","article-title":"Activity of the antifungal protein from Aspergillus giganteus against Botrytis cinerea","volume":"93","author":"Moreno A. B.","year":"2003","journal-title":"Phytopathology"},{"key":"25","volume-title":"NCCLS document M38-A","year":"2002"},{"key":"26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00001432-200312000-00015","article-title":"Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients","volume":"16","author":"Nucci M.","year":"2003","journal-title":"Curr. Opin. Infect. Dis."},{"key":"27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1470-9465.2004.00843.x","article-title":"Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment","volume":"10","author":"Prabhu R. M.","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CMR.13.2.236","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes J. A.","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"29","volume-title":"EUCAST Discussion Document","author":"Rodriguez-Tudela J. L.","year":"2007"},{"key":"30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jac\/dkm429","article-title":"Treatment of zygomycosis: current and new options","volume":"61","author":"Rogers T. R.","year":"2008","journal-title":"J. Antimicrob. Chemoth."},{"key":"31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/fgbi.1998.1093","article-title":"Lovastatin triggers an apoptosis-like cell death process in the fungus Mucor racemosus","volume":"25","author":"Roze L. V.","year":"1998","journal-title":"Fungal. Genet. Biol."},{"key":"32","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1128\/AAC.00163-06","article-title":"In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts","volume":"50","author":"Sabatelli F.","year":"2006","journal-title":"Antimicrob. Agents Ch."},{"key":"33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter M.","year":"2004","journal-title":"Fund. Clin. Pharmacol."},{"key":"34","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/597039","article-title":"Antimicrobial and immunomodulatory attributes of statins: Relevance in solid-organ transplant recipients","volume":"48","author":"Sun H.-Y.","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1556\/ABiol.56.2005.3-4.17","article-title":"Genotypic analysis of variability in zygomycetes","volume":"56","author":"Tak\u00f3 M.","year":"2005","journal-title":"Acta Biol. Hung."},{"key":"36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2217\/17460913.2.2.115","article-title":"Combination antifungal therapy: the new frontier","volume":"2","author":"Vazquez J. A.","year":"2007","journal-title":"Future Microbiol."},{"key":"37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1469-0691.2003.00489.x","article-title":"Microbial natural products as a source of antifungals","volume":"9","author":"Vicente M. F.","year":"2003","journal-title":"Clin. Microbiol. Infect."},{"key":"38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1470-9465.2004.00839.x","article-title":"Infections due to emerging and uncommon medically important fungal pathogens","volume":"10","author":"Walsh T. J.","year":"2004","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Acta Biologica Hungarica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/akademiai.com\/doi\/pdf\/10.1556\/abiol.61.2010.3.11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T14:50:01Z","timestamp":1577458201000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.akademiai.com\/doi\/abs\/10.1556\/ABiol.61.2010.3.11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["10.1556\/ABiol.61.2010.3.11"],"URL":"https:\/\/doi.org\/10.1556\/abiol.61.2010.3.11","relation":{},"ISSN":["0236-5383","1588-256X"],"issn-type":[{"value":"0236-5383","type":"print"},{"value":"1588-256X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}